Picornaviruses & Respiratory Diseases
Picornaviruses are the most frequent cause of viral infections in humans. Based on a proprietary, novel common Host Factor recently published in the renowned scientific Journal Nature, Haplogen develops pan-picorna antiviral compounds protecting from viral infection.
Among the many potential applications of such a drug Haplogen, has initially focussed on the treatment of the most frequent viral infection by the large and diverse family of human rhinoviruses, causing the common cold. There are no preventive or curative medications available. The patient group with the most pressing medical need for such a treatment are patients with obstructive lung diseases such as Asthma and COPD patients, where common cold is a major cause of exacerbations, hospitalizations and disease progression to more severe stages.